Comparison
GHRP-6 vs Lion's Mane
Side-by-side of GHRP-6 and Lion's Mane. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
GHRP-6
First-generation hexapeptide ghrelin-receptor agonist. Pioneered the GHS-R1a pathway in the 1980s. Produces the strongest hunger response among GHRPs and a mo.
Lion's Mane
Lion's mane mushroom (Hericium erinaceus) supplement profile: hericenones and erinacines stimulate NGF in vitro. Human cognition trials are small.
Effects at a glance
GHRP-6
- •First-generation hexapeptide ghrelin-receptor agonist; foundational to the GHRP class
- •Strongest appetite stimulation of any synthetic GHRP at equivalent GH doses
- •Produces measurable cortisol and prolactin rise alongside the GH pulse
- •Anecdotal protocols use 100 to 200 mcg subcutaneously 2 to 3 times daily on an empty stomach
- •Largely superseded by ipamorelin (cleaner profile) and GHRP-2 (stronger pulse) for body-composition use
- •Banned by WADA under S2; detection methods validated in accredited labs
Lion's Mane
- •Edible medicinal mushroom containing NGF-stimulating hericenones and erinacines
- •Mori 2009 trial (n=30) in mild cognitive impairment showed cognitive improvement at 3 g/day for 16 weeks, reversing 4 weeks after discontinuation
- •Saitsu 2019 (n=31) in older adults reported MoCA improvements at 3.2 g/day over 12 weeks
- •Multiple small mood trials suggest reduced anxiety and depression scores at 1 to 4 g/day extract
- •Mechanistic case rests on NGF stimulation and remyelination support; in vivo human NGF measurement is absent
- •Product quality varies substantially; mycelium-on-grain products can be over 50% grain by weight
Side-by-side
| Attribute | GHRP-6 | Lion's Mane |
|---|---|---|
| Category | peptide | natural |
| Also known as | Growth Hormone Releasing Peptide 6, SKF-110679, Histidyl-D-Tryptophyl-Alanyl-Tryptophyl-D-Phenylalanyl-Lysinamide | Hericium erinaceus, Yamabushitake, Bearded Tooth, Hou Tou Gu |
| Half-life (hr) ↗ | 0.5 | 6 |
| Typical dose (mg) ↗ | 0.1 | 1000 |
| Dosing frequency | 2-3x daily | 1 to 2 times daily |
| Routes | subcutaneous, intravenous | oral |
| Onset (hr) | 0.25 | 168 |
| Peak (hr) | 0.5 | 1344 |
| Molecular weight | 872.44 | - |
| Molecular formula | C46H56N12O6 | mixed extract |
| Mechanism | Hexapeptide agonist of GHS-R1a (ghrelin receptor). Suppresses hypothalamic somatostatin and stimulates pituitary somatotrophs, with strong central NPY/AgRP appetite signaling and modest cortisol and prolactin release. | Hericenones and erinacines stimulate NGF mRNA expression and NGF protein release in cultured neurons; secondary anti-inflammatory and remyelination-supportive activity in preclinical models. |
| Legal status | Not FDA approved; research-use-only grey market; banned by WADA | Dietary supplement and food worldwide; unscheduled and unrestricted |
| WADA status | banned | allowed |
| DEA / Rx | Not scheduled (research chemical) | OTC supplement and food |
| Pregnancy | Insufficient data; not recommended | Insufficient data for routine supplementation; consumed historically as food without documented harm |
| CAS | 87616-84-0 | |
| PubChem CID | 9919072 | |
| Wikidata | Q5519921 | Q146050 |
Safety profile
GHRP-6
Common side effects
- intense hunger
- water retention
- vivid dreams
- head pressure or flushing
- tingling at injection site
- transient lethargy
Contraindications
- pregnancy
- active malignancy
- history of pituitary tumor
- uncontrolled diabetes
- prolactin sensitivity
Interactions
- CJC-1295: synergistic GH release; commonly co-administered(minor)
- sermorelin: additive GH release via parallel GHRH and ghrelin pathways(minor)
- insulin: sustained GH can blunt insulin sensitivity over weeks(moderate)
- corticosteroids: blunt GH response and amplify cortisol load(moderate)
Lion's Mane
Common side effects
- mild GI upset
- occasional skin rash
- contact dermatitis (rare)
Contraindications
- mushroom allergy
Interactions
- anticoagulants: theoretical antiplatelet effect, no documented clinical events(minor)
Which Should You Take?
Lion's Mane comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. GHRP-6 is the right call when one of the conditionals below applies.
- → If your priority is growth-hormone axis, pick GHRP-6.
- → If your priority is appetite regulation, pick GHRP-6.
- → If your priority is focus or working memory, pick Lion's Mane.
- → If your priority is nerve health, pick Lion's Mane.
Edge case: If you want to avoid research-only / gray-market sourcing, Lion's Mane is the more accessible choice.
Default choice: Lion's Mane. Lower friction to source, and broader goal coverage. Reach for GHRP-6 only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between GHRP-6 and Lion's Mane?
GHRP-6 and Lion's Mane differ in category (peptide vs natural), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, GHRP-6 or Lion's Mane?
GHRP-6 half-life is 0.5 hours; Lion's Mane half-life is 6 hours.
Can you stack GHRP-6 with Lion's Mane?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper